Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients

Blood Coagulation and Fibrinolysis

Volumn 23, Issue 3, 2012, Pages 189-194

  Za̧bczyk, Michał ^a   Butenas, Saulius ^b   Plicner, Dariusz ^a,c   Fijorek, Kamil ^c   Sadowski, Jerzy ^a,c   Undas, Anetta ^a,c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF VERMONT   (United States)

^c CRACOW UNIVERSITY OF ECONOMICS   (Poland)

Author keywords

coagulation; coronary artery disease; oxidative stress; stable angina; thrombin generation; tissue factor

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 11A; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CYTOKINE RELEASE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; TH1 CELL; TH2 CELL;

AGED; ANGINA PECTORIS; BLOOD COAGULATION; CYTOKINES; DINOPROST; FACTOR XIA; FEMALE; HUMANS; IMMUNOASSAY; LIPOPROTEINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTHROMBIN; RISK FACTORS; TH1-TH2 BALANCE; THROMBIN; THROMBOPLASTIN;

EID: 84859426133     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32834ee194     Document Type: Article

References (36)

1. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111:3481-3488. (Pubitemid 40923403)
2. Hetland Ø, Knudsen A, Dickstein K, Nilsen DW. Characteristics and prognostic impact of plasma fibrin monomer (soluble fibrin) in patients with coronary artery disease. Blood Coagul Fibrinolysis 2002; 13:301-308. (Pubitemid 35001870)
3. Butenas S, Undas A, Gissel MT, Szuldrzynski K, Zmudka K, Mann KG. Factor XIa and tissue factor activity in patients with coronary artery disease. Thromb Haemost 2008; 99:142-149.
4. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92:657-671.
5. Edgington TS, Dickinson CD, Ruf W. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation. Thromb Haemost 1997; 78:401-405. (Pubitemid 27289275)
6. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 2004; 24:1015-1022.
7. Hedner U, Erhardtsen E. Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI. Ann Med 2000; 32:s68-s72.
8. Novotny WF, Brown SG, Miletich JP, Rader DJ, Broze GJ Jr. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patients samples. Blood 1991; 78:387-393.
9. Alban S. Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma. Semin Thromb Hemost 2001; 27:503-511. (Pubitemid 32989375)
10. Cawthern KM, van 't Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG. Blood coagulation in hemophilia A and hemophilia C. Blood 1998; 91:4581-4592. (Pubitemid 28270306)
11. Kravtsov DV, Matafonov A, Tucker EI, Sun MF, Walsh PN, Gruber A, Gailani D. Factor XI contributes to thrombin generation in the absence of factor XII. Blood 2009; 114:452-458.
12. Steppich BA, Braun SL, Stein A, Demetz G, Groha P, Schömig A, et al. Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction. Thromb J 2009; 7:11.
13. Siegemund A, Petros S, Siegemund T, Scholz U, Seyfarth HJ, Engelmann L. The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI. Blood Coagul Fibrinolysis 2004; 15:241-244. (Pubitemid 38561551)
14. Merlo C, Wuillemin WA, Redondo M, Furlan M, Sulzer I, Kremer-Hovinga J, et al. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis 2002; 161:261-267. (Pubitemid 34219178)
15. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002; 162:221-225. (Pubitemid 34327362)
16. Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 2004; 110:1747-1753. (Pubitemid 39299216)
17. Basarici I, Altekin RE, Demir I, Yilmaz H. Associations of isoprostanesrelated oxidative stress with surrogate subclinical indices and angiographic measures of atherosclerosis. Coron Artery Dis 2007; 18:615-620. (Pubitemid 351339514)
18. Zakynthinos E, Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol 2009; 53:317-333.
19. Wang B, Pan J, Wang L, Zhu H, Yu R, Zou Y. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis 2006; 184:425-430. (Pubitemid 43049730)
20. Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, Novembrino C, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001; 47:887-892. (Pubitemid 32398040)
21. JawieńJ. New insights into immunological aspects of atherosclerosis. Pol Arch Med Wewn 2008; 118:127-131. (Pubitemid 351488259)
22. Pedicord DL, Seiffert D, Blat Y. Feedback activation of factor XI by thrombin does not occur in plasma. Proc Natl Acad Sci U S A 2007; 104:12855-12860. (Pubitemid 47255244)
23. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 2006; 32:s32-s38.
24. Wielders SJ, Béguin S, Hemker HC, Lindhout T. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available. Arterioscler Thromb Vasc Biol 2004; 24:1138-1142. (Pubitemid 38737843)
25. Palmier MO, Hall LJ, Reisch CM, Baldwin MK, Wilson AG, Wun TC. Clearance of recombinant tissue factor pathway inhibitor (TFPI) in rabbits. Thromb Haemost 1992; 68:33-36.
26. Misumi K, Ogawa H, Yasue H, Soejima H, Suefuji H, Nishiyama K, et al. Circadian variation in plasma levels of free-form tissue factor pathway inhibitor antigen in patients with coronary spastic angina. Jpn Circ J 1998; 62:419-424.
27. Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, et al., PRIME Study Group. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 2004; 109:1343-1348. (Pubitemid 38387818)
28. Soejima H, Ogawa H, Yasue H, Kaikita K, Nishiyama K, Misumi K, et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 1999; 99:2908-2913. (Pubitemid 29258979)
29. Szu?drzyński K, Zalewski J, Machnik A, Zmudka K. Elevated levels of 8-isoprostaglandin F2alpha in acute coronary syndromes are associated with systemic and local platelet activation. Pol Arch Med Wewn 2010; 120:19-24.
30. Tang M, Cyrus T, Yao Y, Vocun L, Praticò D. Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipoprotein E-and LDL receptor-deficient mice. Circulation 2005; 112:2867-2874. (Pubitemid 41641682)
31. Fontana L, Giagulli C, Minuz P, Lechi A, Laudanna C. 8-Iso-PGF2 alpha induces beta 2-integrin-mediated rapid adhesion of human polymorphonuclear neutrophils: a link between oxidative stress and ischemia/ reperfusion injury. Arterioscler Thromb Vasc Biol 2001; 21:55-60. (Pubitemid 32061927)
32. Herkert O, Diebold I, Brandes RP, Hess J, Busse R, Görlach A. NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells. Circulation 2002; 105:2030-2036. (Pubitemid 34465264)
33. Sanguigni V, Ferro D, Pignatelli P, Del Ben M, Nadia T, Saliola M, et al. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia. J Am Coll Cardiol 2005; 45:35-42. (Pubitemid 40052023)
34. Steffel J, Lüscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006; 113:722-731.
35. Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol 2005; 25:287-294. (Pubitemid 40189147)
36. Zabczyk M, Butenas S, Palka I, Nessler J, Undas A. Active tissue factor and activated factor XI in circulating blood of patients with systolic heart failure due to ischemic cardiomyopathy. Pol Arch Med Wewn 2010; 120:334-340.